Liming Chen
Impact in
-
- Diabetes Treatment and Management
- Nephrology top 2%
Papers in
-
- Metabolism, Diabetes, and Cancer 19
-
- Diabetes Treatment and Management 18
- Diabetes Management and Research 9
- Co-authors
- Bei Sun (43 shared papers)Mei Xue (18 shared papers)Ying Cheng (15 shared papers)Fei Han (11 shared papers)Yunhong Lu (8 shared papers)Xiaochen Yu (11 shared papers)Linxin Xu (10 shared papers)Liping Han (7 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (6 papers)Frontiers in Endocrinology (6 papers)PLoS ONE (4 papers)Metabolism (4 papers)Journal of Diabetes (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Liming Chen
169 papers receiving 4.6k citations
Liming Chen's Hit Papers
Peers
Comparison fields: 5 of 145
- Endocrinology, Diabetes and Metabolism 949
- Nephrology 328
- Complementary and alternative medicine 251
- Hepatology 196
- Genetics 234
Countries citing papers authored by Liming Chen
This map shows the geographic impact of Liming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Chen more than expected).
Fields of papers citing papers by Liming Chen
This network shows the impact of papers produced by Liming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Chen. The network helps show where Liming Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart Hit paper breakdown → | 2019 | 463 |
| 2 | 2012 | 293 | |
| 3 | 2006 | 246 | |
| 4 | 2017 | 119 | |
| 5 | 2018 | 105 | |
| 6 | 2020 | 101 | |
| 7 | 2011 | 98 | |
| 8 | 2020 | 97 | |
| 9 | 2018 | 97 | |
| 10 | 2021 | 93 | |
| 11 | 2019 | 89 | |
| 12 | 2017 | 78 | |
| 13 | 2016 | 73 | |
| 14 | 2020 | 73 | |
| 15 | 2014 | 67 | |
| 16 | 2016 | 66 | |
| 17 | 2019 | 65 | |
| 18 | 2019 | 58 | |
| 19 | 2019 | 55 | |
| 20 | 2020 | 52 |
About Liming Chen
Liming Chen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Epidemiology and Nephrology, having authored 176 papers that have together received 4.6k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (19 papers), Diabetes Treatment and Management (18 papers), Pancreatic function and diabetes (16 papers), Chronic Kidney Disease and Diabetes (9 papers), Diabetes Management and Research (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Diabetes and associated disorders (6 papers) and Adipose Tissue and Metabolism (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (949 citations), Nephrology (328 citations), Complementary and alternative medicine (251 citations), Hepatology (196 citations) and Genetics (234 citations). Liming Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Bei Sun, Mei Xue, Ying Cheng, Fei Han, Yunhong Lu, Xiaochen Yu, Linxin Xu, Liping Han, Yunpeng Chang and Liqin Tang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Frontiers in Endocrinology, PLoS ONE, Metabolism and Journal of Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.